| HealthPartners | Infectious disease testing: multisystem | 2026-07-01 |
| HealthPartners | Infectious disease testing: respiratory | 2026-07-01 |
| HealthPartners | Infectious disease testing: vector-borne | 2026-07-01 |
| HealthPartners | Intra-articular hyaluronan (Viscosupplementation) | 2026-07-01 |
| HealthPartners | Natalizumab (Tysabri®, Tyruko®) | 2026-07-01 |
| HealthPartners | Natalizumab (Tysabri®, Tyruko®) - Minnesota Health | 2026-07-01 |
| HealthPartners | Neonatal Fc receptor antagonists (Vyvgart®, Vyvgart® | 2026-07-01 |
| HealthPartners | Ocrelizumab (Ocrevus®) and ocrelizumab hya-ocsq | 2026-07-01 |
| HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla®), | 2026-07-01 |
| HealthPartners | Oncology - ado-trastuzumab emtansine (Kadcyla®), | 2026-07-01 |